Summary
- Current Price
- As of today, ATRA price is $9.44, up +1.07% in the most recent trading session on
- Current Price All-Time High
- ATRA price is currently -99.42% below its historical high of $1,639.00 set on
- Market Cap
- ATRA current market cap is $85M, up +76.04% over the past 365 days
- PE Ratio
- ATRA PE ratio is unknown
- Revenue
- ATRA current annual revenue is $120.77M, down -6.33% year-over-year
- Next Earnings
- The next earnings release for ATRA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Atara Biotherapeutics, Inc. |
| Ticker | NASDAQ: ATRA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | atarabio.com |
| Employees | 89 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $9.44 | ||
| Price, 1D Change | +1.07% | |
| $85M | ||
| - | ||
| - | ||
| 1.50 | ||
| $121M | ||
| Revenue, 1Y Change | -6.33% | |
| $2.57 | ||
| EPS, 1Y Change | +122.54% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:25 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $2.57 | ||
| EPS Estimate | N/A | $0.30 |
| EPS Est. Change | N/A | -88.52% |
| $120.77M | ||
| Revenue Estimate | N/A | $16.85M |
| Revenue Est. Change | N/A | -86.05% |
| $9.44 | ||
| Price Target | - | $13.00 |
| Price Tgt. Change | - | +37.71% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.24 | -$11.41 | -168.99% | |
| $2.79 | $2.57 | -7.88% | |
| $0.30 | N/A | -88.52% | |
| $1.64 | N/A | -36.32% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $112.74M | $128.94M | +14.37% | |
| $120.83M | $120.77M | -0.04% | |
| $16.85M | N/A | -86.05% | |
| $45.83M | N/A | -62.06% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +32.77% | ||
| -82.02% | ||
| +76.04% | ||
| -58.66% | ||
| -6.33% | ||
| +89.97% | ||
| +122.54% | ||
| +214.82% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $9.44 | ||
| $10.16 | ||
| SMA 200 vs Price | +7.63% | |
| $6.01 | ||
| SMA 50 vs Price | -36.35% | |
| 1.50 | ||
| $1.02 | ||
| 64.60 | ||
| 126.26% | ||
| 143.83% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $120.77M | ||
| $2.57 | ||
| $99.56M | ||
| 82.44% | ||
| $49.77M | ||
| 41.21% | ||
| $32.69M | ||
| 27.07% | ||
| $50.41M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -1.37 | ||
| 0.82 | ||
| 0.82 | ||
| - | ||
| 2 | ||
| -115.59 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 3.68 | ||
| -2.28 | ||
| -22.25 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$38.50M | ||
| $8.48M | ||
| $21.89M | ||
| $12.21M | ||
| $60.39M | ||
| $14.92M | ||
| $52.80M | ||
| $10.78M | ||
| $127.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $88.08M | ||
| $49.79M | ||
| $21.21M | ||
| $0.00 | ||
| $2.12M | ||
| $0.00 | ||
| $31.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$50.94M | ||
| $18.15M | ||
| $16.10M | ||
| $0.00 | ||
| -$50.94M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Canaccord Genuity | → | |
| Freedom Broker | → | |
| Canaccord Genuity | → | |
| Canaccord Genuity | → | |
| Canaccord Genuity | → | |
| HC Wainwright & Co. | → | |
| Canaccord Genuity | → | |
| Rodman & Renshaw | ||
| Canaccord Genuity | → | |
| HC Wainwright & Co. |
Analyst sentiment
Institutional ownership
Screeners with ATRA
FAQ
What is the ticker symbol for Atara Biotherapeutics, Inc.?
The ticker symbol for Atara Biotherapeutics, Inc. is NASDAQ:ATRA
Does Atara Biotherapeutics, Inc. pay dividends?
No, Atara Biotherapeutics, Inc. does not pay dividends
What sector is Atara Biotherapeutics, Inc. in?
Atara Biotherapeutics, Inc. is in the Healthcare sector
What industry is Atara Biotherapeutics, Inc. in?
Atara Biotherapeutics, Inc. is in the Biotechnology industry
What country is Atara Biotherapeutics, Inc. based in?
Atara Biotherapeutics, Inc. is headquartered in United States
When did Atara Biotherapeutics, Inc. go public?
Atara Biotherapeutics, Inc. initial public offering (IPO) was on October 16, 2014
Is Atara Biotherapeutics, Inc. in the S&P 500?
No, Atara Biotherapeutics, Inc. is not included in the S&P 500 index
Is Atara Biotherapeutics, Inc. in the NASDAQ 100?
No, Atara Biotherapeutics, Inc. is not included in the NASDAQ 100 index
Is Atara Biotherapeutics, Inc. in the Dow Jones?
No, Atara Biotherapeutics, Inc. is not included in the Dow Jones index
When was Atara Biotherapeutics, Inc. last earnings report?
Atara Biotherapeutics, Inc.'s most recent earnings report was on May 12, 2026
When does Atara Biotherapeutics, Inc. report earnings?
The next expected earnings date for Atara Biotherapeutics, Inc. is August 11, 2026
Data Sources & References
- ATRA Official Website www.atarabio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1604464/000119312526108361/0001193125-26-108361-index.htm
- ATRA Profile on Yahoo Finance finance.yahoo.com/quote/ATRA
- ATRA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/atra